Method for synthesizing L-cysteine by transforming DL-2-amino-delta<2>-thiazolinyl-4-carboxylic acid (DL-ATC) by enzyme process
A technology for the conversion of cysteine, enzymatically, in the direction of microbial-based methods, biochemical devices and methods, immobilized on/in organic carriers, etc., capable of addressing variability, short half-life, wild pseudomonas The difficulty of bacterial transformation and other problems
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0057] Example 1 Knockout of Escherichia coli JM109 (DE3) L-cysteine desulfhydrylase gene tnaA
[0058] 1. Materials
[0059] Strains: Escherichia coli JM109 (DE3), purchased from Promega.
[0060] Plasmids: Plasmids pKD4, pKD46, and pCP20 were purchased from Wuhan Miaoling Biotechnology Co., Ltd.
[0061] LB medium: peptone 10g / L, yeast powder 5g / L, NaCl 10g / L.
[0062] Kanamycin-resistant plate: LB solid medium containing 20 mg / L kanamycin and 1.5% agar powder.
[0063] SOC medium: peptone 2g / L, yeast powder 0.5g / L, NaCl0.0585g / L, KCl0.0186g / L, MgCl 2 0.203g, MgSO 4 0.246g / L, glucose 20mmol / L.
[0064] 2. Method
[0065] (1) Cloning of tnaA gene homologous recombination fragment
[0066] The target gene was knocked out using the Red recombination system. Primers were designed according to the sequence of the Escherichia coli tnaA gene (Genebank accession number: K00032.1) published by Genbank:
[0067] tnaAup:
[0068] 5'-ATGGAAAACTTTAAACATCTCCCTGAACCGTTCCGCATTCG...
Embodiment 2
[0088] Example 2 Knockout of Escherichia coli JM109 (DE3) ΔtnaAL-cysteine desulfhydrylase gene malY
[0089] 1. Materials
[0090] Bacterial species: Escherichia coli engineering strain JM109(DE3)ΔtnaA, see Example 1 for its related characteristics.
[0091] Plasmids: Plasmids pKD4, pKD46, and pCP20 were purchased from Wuhan Miaoling Biotechnology Co., Ltd.
[0092] LB medium: peptone 10g / L, yeast powder 5g / L, NaCl 10g / L.
[0093] Kanamycin-resistant plate: LB solid medium containing 20 mg / L kanamycin and 1.5% agar powder.
[0094] SOC medium: peptone 2g / L, yeast powder 0.5g / L, NaCl0.0585g / L, KCl0.0186g / L, MgCl 2 0.203g, MgSO 4 0.246g / L, glucose 20mmol / L.
[0095] 2. Method
[0096] (1) Cloning of malY gene homologous recombination fragment
[0097] The target gene was knocked out using the Red recombination system. Primers were designed according to the sequence of the Escherichia coli malY gene (Genbank accession number: M60722.1) published by Genbank:
[0098] ma...
Embodiment 3
[0119] Example 3 Conversion of DL-ATC to the construction of a metabolic pathway for synthesizing L-cysteine
[0120] 1. Materials
[0121] Bacterial species: Escherichia coli engineering strain JM109(DE3)ΔtnaAΔmalY, see Example 2 for its related characteristics.
[0122] Plasmid: Plasmid pET-28a(+) was purchased from Novagen, and plasmid pACYC184 was purchased from NewEngland Biolabs.
[0123] LB medium: peptone 10g / L, yeast powder 5g / L, NaCl 10g / L.
[0124] DL-ATC racemase gene atcA, L-ATC hydrolase gene atcB, nitrogen-carbamoyl-L-cysteine hydrolase gene atcC are all derived from Pseudomonas sp.BS strain.
[0125] Kanamycin+tetracycline double-antibody plate: LB solid medium containing 1.5% agar, 20mg / L kanamycin, and 10mg / L tetracycline.
[0126] 2. Method
[0127] (1) Construction of atcAB expression vector
[0128]The DL-ATC racemase gene (atcA) (GenBank accession number: BAD15357) and the L-ATC hydrolase gene (atcB) derived from the genome of Pseudomonas sp.BS str...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com